February 2004

Distribution Support Systems

January 2, 2008

Distribution support systems More sophisticated products mean new and more elaborate distribution-support systems are needed to move the manufacturer closer to the patient. In an exclusive to PharmaVOICE, David Hileman, VP of RxCrossroads, discusses the changing dynamics of distribution channels and shortening the distance between manufacturer and patient. T wenty-five years ago, distribution channels for […]

Data Management: Integrating Across the Enterprise

January 2, 2008

Data Management Integrating Across the Enterprise by elisabeth pena As new technologies allow for the generation of more data than ever before, it is crucial that the pharmaceutical industry develop data-management strategies to translate data into actionable information that can be used to drive business decisions. The pharmaceutical industry is expected to spend 42% of […]

For Art’s Sake

January 2, 2008

Creative Review Each month, this department pays homage to memorable advertising and marketing campaigns. The highlighted executions have been identified by leading creative executives for their noteworthy use of copy, art, photography, whimsy, uniqueness, etc. – in combination or as single branding elements. Creating good pharmaceutical advertising and marketing requires agencies to think out of […]

Dear Diary: Unlocking the Patient Experience in Real Time

January 2, 2008

Dear Diary Unlocking the Patient Experience in Real Time By Denise Myshko Patient diaries As cost and implementation concerns over the use of hand-held electronic patient diaries begin to ease, companies are starting to recognize The potential for accessing patient feedback in real time. Electronic diaries can potentially provide better-quality data, faster time to data […]

What’s on Your Mind — Opinions

January 2, 2008

WHAT’S on your mind opinions Crossing the border Lost in rhetoric The issues of assuring the integrity of the U.S. drug supply and patient safety are getting lost in the rhetoric. There needs to be a clear and credible message that the primary concern is that we can not assure the safety of imported drug […]

Nanotechnology: It’s a Small World

January 2, 2008

Nanotechnology It’s a Small World BY DENISE MYSHKO The biggest thing right now in the industry just may be the smallest. A growing interest in nanotechnology – the ability to work at the atomic and molecular levels – is spurring R&D investments in pharmaceutical discovery, diagnostics, and drug delivery. In the long term, this research […]

E-xpanding Sample Delivery

January 2, 2008

There’s an important reconciliation that must be made between the traditional methods of distributing drug samples and using e-sampling as a platform for greater marketplace penetration. How companies incorporate e-sampling into the business plan is the next challenge. Pharmaceutical product sampling is big business. The industry spends about $12 billion in the United States on […]

PharmaCounsel

January 2, 2008

PharmaCounsel Legal Counsel: patent management When Form Equals Substance: The Value of Form Screening in Product Life-Cycle Management Pharmaceutical companies need to better manage product life cycles. companies protect their products with a variety of patents, such as composition, method of used, method of manufacture, and formulation patents. A novel product life-cycle management system implemented […]

E-Media

January 2, 2008

E-Media New electronic and web-based applications, sites, and technologies Oracle’s RDC to Speed Data Collection in Clinical Trials Oracle’s latest release of Clinical Remote Data Capture (RDC) features advances in usability, form design, and support for clinical trials. It provides the staff at doctors’ offices and hospitals with an integrated Web interface for entering patient […]

Thomas Ebeling: A Leader on a Mission

January 2, 2008

A Leader on a Mission BY KIm Ribbink With a strong consumer background, Thomas Ebeling, CEO of Novartis Pharma AG and head of Novartis’ pharmaceuticals division worldwide, has the company positioned for growth. T homas Ebeling’s focus is to make sure Novartis is considered best in class by both doctors and patients. He is applying […]

PharmaOutlet

January 2, 2008

Contributed by Ron Pantello THE HEALTHCARE COMMUNICATIONs INDUSTRY: ON THE BRINK OF FINANCIAL DISASTER? As many of us are witnessing, the healthcare communications industry is under siege. Economic constraints are so severe that the very existence of the industry as we know it is threatened. Yet it appears that many of our customers are completely […]

PharmaTrax

January 2, 2008

Pharma trax Sales, marketing, And R&D Trends affecting the healthcare industry New Drug Commercialization Costs Lead to Blockbuster Model’s End The high cost of commercialization is leading to the demise of the pharma industry’s blockbuster approach to developing new drugs, according to a study from Bain & Company. When the costs of failed prospective drugs […]

Letter From the Editor

January 2, 2008

Pharmaceutical manufacturers spent more in 2003 on new technology in most areas and less on maintaining existing technology than other manufacturing verticals, according to AMR Research. This is to be expected as many move to packaged or Web-based applications. Investments in databases, physical infrastructure, security, the Internet, Web-based electronic data interchange (EDI), and training reflect […]

What’s New

January 2, 2008

New healthcare-related products, services, and companies Market Measures/Cozint Forms Emerging Markets Team Group to focus exclusively on the market research needs of emerging pharma companies. Realizing that smaller and specialized companies involved in the healthcare field have unique requirements that differ from the needs of large pharmaceutical manufacturers, Market Measures/Cozint has recently formed an Emerging […]

Table of Contents

January 2, 2008

on the cover Data management -Integrating across the enterprise As new technologies allow for the generation of more data, it is becoming increasingly crucial for the pharmaceutical industry to develop strategies to translate data into actionable information that can be used to drive business decisions. 8 FEATURES Dear diary: Unlocking the patient experience in real […]

Talent Pool

January 2, 2008

Pharma POOL Roy Dunbar Mike Heim Dr. John Lechleiter Gerhard Mayr Dr. Lorenzo Tallarigo Senior Management Movements at Lilly Roy Dunbar, previously chief information officer of Eli Lilly, Indianapolis, has been appointed president of intercontinental operations, responsible for Asia, Africa, Middle East, Mexico, Brazil, and Andean/Central America. Mr. Dunbar joined Lilly in 1990. He has […]

FEEDBACK